1. Endothelial Dec1-PPARγ Axis Impairs Proliferation and Apoptosis Homeostasis Under Hypoxia in Pulmonary Arterial Hypertension
   Xiaoming Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
2. Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis
   Xinhui Hu et al, 2024, Renal Failure CrossRef
3. Targeting PPARs for therapy of atherosclerosis: A review
   Miao Miao et al, 2023, International Journal of Biological Macromolecules CrossRef
4. The role of nonmyocardial cells in the development of diabetic cardiomyopathy and the protective effects of FGF21: a current understanding
   Tianyi Zhang et al, 2024, Cell Communication and Signaling CrossRef
5. MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension
   Yang-Zhi-Ge He et al, 2023, Vascular Pharmacology CrossRef
6. FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ
   Meibin Wang et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
7. Critical role of FGF21 in diabetic kidney disease: from energy metabolism to innate immunity
   Yingnan Liang et al, 2024, Frontiers in Immunology CrossRef
8. Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation
   Xiu-chun Li et al, 2024, Acta Pharmacologica Sinica CrossRef
9. Panorama of artery endothelial cell dysfunction in pulmonary arterial hypertension
   Ying-Huizi Shen et al, 2024, Journal of Molecular and Cellular Cardiology CrossRef
10. Adipokines in pulmonary hypertension: angels or demons?
    Qi Jia et al, 2023, Heliyon CrossRef
11. Critical miRNAs in regulating pulmonary hypertension: A focus on Signaling pathways and therapeutic Targets
    Di Wang et al, 2023, Analytical Biochemistry CrossRef
12. FGF21 Inhibits Hypoxia/Reoxygenation-induced Renal Tubular Epithelial Cell Injury by Regulating the PPARγ/NF-κB Signaling Pathway
    Ruixue Li et al, 2024, Cell Biochemistry and Biophysics CrossRef
13. Clinical value of lncRNA SOX2-OT in pulmonary arterial hypertension and its role in pulmonary artery smooth muscle cell proliferation, migration, apoptosis, and inflammatory
    Yunfei Jiang et al, 2022, Heart & Lung CrossRef
14. Interleukin-6 and pulmonary hypertension: from physiopathology to therapy
    Wei-Jie Xu et al, 2023, Frontiers in Immunology CrossRef
15. Activating transcription factor 4 aggravates angiotensin II-induced cell dysfunction in human vascular aortic smooth muscle cells via transcriptionally activating fibroblast growth factor 21
    Ke Tao et al, 2022, The Korean Journal of Physiology & Pharmacology CrossRef
16. Sesamol promotes browning of white adipocytes through liver-adipose crosstalk signal of hepatic fibroblast growth factor 21
    Ming-Hui Cheng et al, 2023, The Journal of Nutritional Biochemistry CrossRef
17. FGF21 at physiological concentrations regulates vascular endothelial cell function through multiple pathways
    Ni Yang et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
18. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development
    Jaydev Dave et al, 2023, Journal of Translational Medicine CrossRef